Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Risk Factors
Range for G1733A polymorphism strengthens its potential as prognostic marker
December 29th, 2005
The wide distribution range for the G1733A polymorphism strengthens its potential as a prognostic marker for certain cancers. According to a study from Spain, "The androgen receptor (AR) has been proposed as a candidate gene for several cancers (breast, prostate, uterine endometrium, colon, and esophagus). Ethnicity is considered an associated risk factor for some of these cancers." E. Esteban and colleagues wrote, "Several case-control genetic studies have been focused in samples of the main ethnic groups, but little is known about the distribution of risk polymorphisms in current populations with accurate ethnic and/or geographic origins. The A...
Source: Women's Health Weekly (2005-12-29)
|
